 Purification of Rho  Purification of G t  Purification of the Rho*-G t complex 
. Sequences of peptic fragments from Rho's primary sequence showing normalized hydrogen deuterium uptake for Rho, Rho*, and Rho*-G t complex, related to Figure 6 
Purification of Rho
Following purification of Rho ZnCl 2 was then removed by dialysis in the presence of 0.2 mM DDM. The purity of Rho, assessed spectrophotometrically from its absorption ratio at 280 nm (protein peak) to 500 nm (chromophore peak), was typically 1.8, suggesting that Rho was devoid of opsin and other proteins (Okada et al., 2000; Okada et al., 1998) . Rho also appeared homogenous after SDS-PAGE analysis. The concentration of Rho was calculated by using the absorption coefficient  = 40,600 M -1 cm -1 to quantify its absorption at 500 nm (Matthews et al., 1963) . A typical yield was 40 mg of Rho per 100 bovine retinas. Lipid-free Rho was purified by sConA affinity resin prepared by coupling sConA (Vector Laboratories, CA) to CNBr-activated agarose (Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a density of 8 mg sConA/ml of resin. A column containing sConA resin was equilibrated with 20 mM BTP, pH 6.9, containing 120 mM NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM DTT and 0.5 mM DDM.
ZnCl 2 -opsin extracted Rho was diluted to ~ 0.2 mg/ml and loaded onto the column at 0.5 ml/min. The resin was washed with 10 column volumes of equilibrating buffer and then Rho was eluted at 0.2 ml/min with the same buffer containing 200 mM -methyl-D-mannoside. The protein elution profile was examined by SDS-PAGE and fractions containing Rho were pooled and concentrated with a 30,000 NMWL Centricon device to ~ 3 mg/ml. Protein concentrations were determined as described above.
Purification of G t
Briefly, ROS membranes from 200 retinas were diluted in 30 ml of isotonic buffer (20 mM HEPES, pH 7.5, 5 mM MgCl 2 , 1 mM DTT and 100 mM NaCl) and soluble proteins were removed by gentle homogenization followed by centrifugation at 25,000g at 4 o C for 15 min. G t then was extracted from the pellet in 40 ml of hypotonic buffer (5 mM HEPES, pH 7.5, 0.1 mM EDTA and 1 mM DTT), membranes were collected by centrifugation at 25,000g at 4 o C for 30 min and the supernatant was saved for further purification. This extraction procedure was repeated three times. Combined supernatants were centrifuged at 25,000g for 60 min to remove ROS membrane contaminants, and then HEPES, pH 7.5, was introduced from a 1 M stock solution to achieve a final concentration of 10 mM and MgCl 2 was added to a final concentration of 2 mM. This solution was applied to 3 ml of pentyl-agarose resin equilibrated with buffer composed of 10 mM HEPES, pH 7.5, 2 mM MgCl 2 and 1 mM DTT at a flow rate of 15 ml/h.
The resin then was washed with 10 column volumes of equilibrating buffer. Bound proteins were eluted with a 50 ml linear gradient of 0 to 0.5 M NaCl in the equilibrating buffer at a flow rate of 15 ml/h, and 1 ml fractions were collected. Fractions containing G t were pooled and concentrated by a 30,000 NMWL Centricon device (Millipore, Billerica, MA). G t was purified to homogeneity on a Superdex 200 gel filtration column equilibrated with buffer containing 10 mM HEPES, pH 7.5, 100 mM NaCl, 2 mM MgCl 2 , and 1 mM DTT at 4 o C (flow rate 0.4 ml/min with collection of 0.4 ml fractions). Fractions containing G t were combined and concentrated by a 30,000 NMWL Centricon device to ~10 mg protein/ml as determined by the Bradford assay (Bradford, 1976) . A typical purification yielded ~ 2 mg of G t with 95% purity from 200 bovine retinas.
Purification of the Rho*-G t complex
Briefly, a column containing CNBr-sConA resin was equilibrated with buffer composed of 20 mM BTP, pH 6.9, containing 120 mM NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM DTT and 0.5 mM DDM. ZnCl 2 -opsin-extracted Rho was diluted with this equilibrating buffer to ~ 0.2 mg/ml and loaded on the column. The resin was washed with 5 column volumes of the same buffer and then exposed for 10 min to light located 10 cm away (150 Watt filter light, Dolan Jenner Industries Inc.) that passed through a 480-520 nm band pass filter. Purified G t diluted to ~ 0.2 mg/ml with equilibrating buffer was applied to the column immediately after light exposure. The resin was washed with 10 column volumes of equilibrating buffer and bound protein was eluted with buffer composed of 20 mM BTP, pH 6.9, containing 120 mM NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM DTT, 0.5 mM DDM and 200 mM -methyl-Dmannoside. The protein elution profile was examined by SDS-PAGE and fractions containing the Rho*-G t complex were pooled. This preparation was used directly for footprinting experiments or combined fractions were concentrated to ~ 3 mg/ml with a 30,000 NMWL Centricon device (Millipore, Billerica, MA) for hydrogen-deuterium exchange experiments.
Concentrations of the purified Rho*-G t complex were determined by Bradford ULTRA (Novexin, UK) with bovine serum albumin used as the standard. Column 1 shows the peptide sequence from the Rho primary sequence. Amino acid residues from the primary sequences of Rho found to have modifications such as attached carbohydrates, disulfide bonds, or palmitate are shown in bold underlined letters. Column 2 exhibits the m/z of the ion used to identify the peptide based on the MS/MS spectrum, column 3 indicates the charge of the ion from column 2, column 4 shows the retention time (min) obtained from the HPLC chromatogram and used to identify the deuterated species, column 5 features the number of theoretically exchangeable sites of the peptide fragment (see detailed calculation based on peptide sequence and sample dilution described in section "Analysis of hydrogen-deuterium exchange"), columns 6 to 10 indicate uptakes normalized to 80% of the theoretical maximum exchangeable sites (column 5) of Rho with lipids, Rho in pure detergent, Rho* with lipids, Rho* in pure detergent, and of the Rho*-Gt complex. Error values represent SDs obtained from three independent measurements. ND signifies unreliable detection of the peptide signal based on either overlap with other deuterated signals, an intensity lower than four times the preset mass spectrometer imposed baseline, or an absence from the spectrum. Table S2 , related to Figure 6 . Sequences of peptic fragments of G tα 's primary sequence showing normalized hydrogen deuterium uptake for G tα free or in complex with Rho*. Column 1 indicates the peptide sequence from the primary sequence of G tα . Column 2 shows the m/z of the ion used to identify the peptide based on the MS/MS spectrum, column 3 exhibits the charge of the ion from column 2, column 4 indicates the retention time (min) obtained from the HPLC chromatogram and used to identify the deuterated species, column 5 reveals the number of theoretically exchangeable sites of the peptide fragment (see detailed calculation based on peptide sequence and sample dilution described in section "Analysis of hydrogen-deuterium exchange"), column 6 denotes uptake normalized to 80% of the theoretical maximum exchangeable sites (column 5) of G tα whereas column 7 shows normalized uptake of G tα in the presence of Rho*. Error values represent SDs obtained from three independent measurements. ND signifies unreliable detection of the peptide signal based on either overlap with other deuterated signals, an intensity lower than four times the preset mass spectrometer imposed baseline, or an absence from the spectrum. 3+ 12.6-13.0 17.6 3.9±2.5 35.6±6. 4 L 33 LLGAGESGKSTIVKQ 801.3 3 2+ 11.2-11.4 12.0 28.3±7.5 66.2±3. 8 L 33 LLGAGESGKSTIVKQMKIIHQDG YSLE 1006 . 36 3+ 12.2-12.3 21.6 40.7±5.5 62.5±1. 3 I 67 AIIYGNTLQ 1106 Table S1 (columns 6 to 10) and these were used for color coding of Rho's primary sequence. Color coding is shown as 0-9%; blue, 10-19%; light blue, 20-29%; cyan, 30-39%; green, 40-49%; yellow, 50-59%; orange, 60-69%; red, 70-79%; pink, 80-100% Figure S2 , related to Figure 8 . Hydrogen-deuterium exchange of Rho* in the presence of G t . This figure shows the deuterium uptake of Rho peptic peptide fragments obtained from Rho*-G t samples. Calculation of the normalized deuterium uptake and the color-coding employed are described in Fig. S1 . Figure S3 , related to Figure 9 . Hydrogen-deuterium exchange of G t α in the presence and absence of Rho*. Panel A shows the recent model of Rho*-G t (1) with the mapped hydrogen deuterium exchange profile of the α domain of G t in the presence of Rho*. Calculation of the normalized deuterium uptake is based on Table S2 whereas the color-coding used is described in Fig. S1 . The Rho* dimer together with G tβ and G tγ domains are shown as gray cartoons. Panel B illustrates a 90° rotated view of the G tα domain shown in Panel A. The G t AH and G t Ras subdomains are labeled appropriately. Panel C shows the deuterium uptake profile of G t α in the absence of Rho*.
